Evidence map›Paper›PMID 30691056›Full record

ArticleJournal of clinical medicine2019

Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme.

Nagaraj Malipatil, Helene A Fachim, Kirk Siddals, Bethany Geary, Gwen Wark, Nick Porter, Simon Anderson, Rachelle Donn, Michelle Harvie, Anthony D Whetton and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Proteomics of the heart.Physiological reviews · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in Research on Diabetes by Human Nutriomics.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nagaraj MalipatilThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. nagaraj.malipatil@nhs.net.
Helene A FachimThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. helene.fachim@manchester.ac.uk.
Kirk SiddalsThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. kirk.siddals@manchester.ac.uk.
Bethany GearyThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. bethany.geary@manchester.ac.uk.
Gwen WarkSAS Peptide Hormone Section, Part of Berkshire and Surrey Pathology Services, Royal Surrey County Hospital, Guildford GU2 7XX, UK. gwen.wark@nhs.net.
Nick PorterSAS Peptide Hormone Section, Part of Berkshire and Surrey Pathology Services, Royal Surrey County Hospital, Guildford GU2 7XX, UK. nick.porter@nhs.net.
Simon AndersonThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. simon.anderson@manchester.ac.uk.ORCID 0000-0002-8896-073X
Rachelle DonnThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. rachelle.donn@manchester.ac.uk.ORCID 0000-0001-6976-9828
Michelle HarvieThe Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK. michelle.harvie@manchester.ac.uk.
Anthony D WhettonThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. tony.whetton@manchester.ac.uk.
Martin J GibsonThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. martin.gibson@manchester.ac.uk.
Adrian HealdThe School of Medical Sciences and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, M13 9PL, UK. adrian.heald@manchester.ac.uk.
Manchester Academic Health Science Centre · GBRoyal Surrey County Hospital · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/M008959/1Medical Research Council MR/N00583X/1
6 · The paper itself

Abstract

We investigated biological determinants that would associate with the response to a diet and weight loss programme in impaired glucose regulation (IGR) people using sequential window acquisition of all theoretical fragment ion spectra (SWATH) mass spectrometry (MS), a data acquisition method which complement traditional mass spectrometry-based proteomics techniques. Ten women and 10 men with IGR underwent anthropometric measurements and fasting blood tests. SWATH MS was carried out with subsequent immunoassay of specific peptide levels. After a six-month intervention, 40% of participants lost 3% or more in weight, 45% of patients remained within 3% of their starting weight and 15% increased their weight by 3% or more. Hemoglobin A1c (HbA1C) level was reduced with weight loss with improvements in insulin sensitivity. SWATH MS on pre-intervention samples and subsequent principal component analysis identified a cluster of proteins associated with future weight loss, including insulin-like growth factor-II (IGF-II) and Vitamin D binding protein. Individuals who lost 3% in weight had significantly higher baseline IGF-II levels than those who did not lose weight. SWATH MS successfully discriminated between individuals who were more likely to lose weight and potentially improve their sensitivity to insulin. A higher IGF-II baseline was predictive of success with weight reduction, suggesting that biological determinants are important in response to weight loss and exercise regimes. This may permit better targeting of interventions to prevent diabetes in the future.

Indexed as

IGRlifestyle changeproteomicsSWATH MS

Identifiers

PMID30691056
PMCPMC6406968
OpenAlexW2913789379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.